Kisunla (Donanemab) adverse drug reaction and premedication

PLEASE NOTE: Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP).

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to cmichalek@ismp.org.

2 posts / 0 new

Last post

Mon, 08/03/2026 - 11:15

Juby Panicker

Offline

Last seen: 6 days 6 hours ago

Joined: 03/04/2026 - 11:52

Kisunla (Donanemab) adverse drug reaction and premedication

Hi all,

We are reviewing some adverse drug reactions reported with Kisunla (donanemab) and have noticed that the reactions occurred at varying dose levels.

For those of you administering donanemab, do you have any premedications built into your therapy plans or order panels? We would like to hear about your protocols and any lessons learned from your experience.

Thanks in advance for any insights you can share!

Kind regards,
Juby Panicker
Quality and Safety Clinical Pharmacist
UT Southwestern Medical Center
Dallas, Texas

Members Log In